Tektel-M 25 Tablet ER
Marketer
Tricorn Healthcare
Salt Composition
Telmisartan (40mg) + Metoprolol Succinate (23.75mg)
Overview Tektel-M 25 Tablet ER
Cardio-M 25 Extended-Release tablets manage hypertension, reducing the risk of strokes and heart attacks. Early use enhances survival rates following a heart attack. Consistent blood levels are achieved by taking Cardio-M 25 ER with food daily at the same time, as prescribed. Continue treatment even if feeling well, as hypertension is often asymptomatic; premature discontinuation can worsen the condition. Lifestyle changes, including regular exercise, weight management, and a healthy diet, complement medication. Always follow your physician's instructions. Potential side effects include headache, weakness, dizziness, hypotension (occasionally with fainting), elevated potassium levels, shortness of breath, nausea, vomiting, abdominal pain, and fatigue. Avoid potassium-rich foods and supplements. Dizziness may occur; avoid driving and rise slowly from seated positions. Regular monitoring of blood pressure, blood sugar, kidney function, urea, and electrolytes may be necessary. Inform your doctor of any liver or kidney issues before starting treatment. Pregnant or breastfeeding individuals should seek medical advice before use. Disclose all current medications, particularly those for hypertension or heart conditions.
Uses of Tektel-M 25 Tablet ER
Managing elevated blood pressure
Major Benefits of Tektel-M 25 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Tektel-M 25 Tablet ER whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet with food.
Common Side effects of Tektel-M 25 Tablet ER:
- Headache
- Weakness
- Dizziness
- Cold extremities
- Slow heart rate
- Increased potassium level in blood
- Decreased blood pressure
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Breathlessness
- Vomiting
- Abdominal pain
How to use Tektel-M 25 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Tektel-M 25 Tablet ER. Ingest the tablet whole; avoid crushing, chewing, or breaking it. This medication should be administered with a meal.
How Tektel-M 25 Tablet ER works:
Tektel-M 25 Extended-Release tablets contain a dual-action formulation of telmisartan and metoprolol succinate, both effective in reducing blood pressure.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol consumption while taking Tektel-M 25 Tablet ER.
PregnancyCONSULT YOUR DOCTOR
Extended-release Tektel-M 25mg tablets present a confirmed risk to fetal development and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is advised.
Breast feedingSAFE IF PRESCRIBED
Extended-release Tektel-M 25 mg tablets are likely safe for breastfeeding mothers. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Extended-release Tektel-M 25mg tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
Tektel-M 25 Extended-Release tablets are considered safe for use in individuals with renal impairment. No modification of the Tektel-M 25 Extended-Release tablet dosage is necessary.
LiverCAUTION
Exercise caution when prescribing Tektel-M 25 Extended-Release tablets to individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is recommended.
What if you forget to take Tektel-M 25 Tablet ER :
Should you forget to take a Tektel-M 25 Tablet ER, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Tektel-M 25 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Heart |

